Evonik (0QDS) Share Forecast & Price Target

Compare

5 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QDS Analyst Ratings

Hold

2 Buy

7 Hold

3 Sell

Based on 12 analysts giving stock ratings to

Evonik

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QDS Stock 12 Month Forecast

Average Price Target

€15.00

▲(6.23% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Evonik in the last 3 months. The average price target is €15.00 with a high forecast of €20.40 and a low forecast of €12.20. The average price target represents a 6.23% change from the last price of €14.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"€11","16":"€16","21":"€21","13.5":"€13.5","18.5":"€18.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€20.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,13.5,16,18.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.326,14.79323076923077,15.260461538461538,15.727692307692308,16.194923076923075,16.662153846153846,17.129384615384616,17.596615384615383,18.063846153846153,18.531076923076924,18.99830769230769,19.46553846153846,19.932769230769228,{"y":20.4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.326,14.377846153846153,14.429692307692308,14.481538461538461,14.533384615384616,14.585230769230769,14.637076923076924,14.688923076923077,14.740769230769232,14.792615384615384,14.84446153846154,14.896307692307692,14.948153846153847,{"y":15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.326,14.162461538461539,13.998923076923077,13.835384615384616,13.671846153846154,13.508307692307692,13.34476923076923,13.181230769230769,13.017692307692307,12.854153846153846,12.690615384615384,12.527076923076923,12.363538461538461,{"y":12.2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.95,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.815,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.484,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.877,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.186,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.522,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.879,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.691,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.183,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.265,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.03,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":14.326,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€20.40

Average Price Target€15.00

Lowest Price Target€12.20

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anil Shenoy

Barclays

€16→€17

Buy

20.40%

Upside

Upgraded

03/19/26

Barclays upgrades Evonik (0QDS) to a Buy

Martin Roediger

Kepler Capital

€12.7

Sell

-10.06%

Downside

Reiterated

03/10/26

Kepler Capital Sticks to Their Sell Rating for Evonik (0QDS)

Christian Bell

UBS

€13

Hold

-7.93%

Downside

Reiterated

03/04/26

UBS Remains a Hold on Evonik (0QDS)

Chetan Udeshi

J.P. Morgan

―

Hold

―

Reiterated

03/04/26

J.P. Morgan Sticks to Their Hold Rating for Evonik (0QDS)

Chris Counihan

Jefferies

€12.2

Sell

-13.60%

Downside

Reiterated

03/04/26

Jefferies Keeps Their Sell Rating on Evonik (0QDS)

Peter Spengler

DZ BANK AG

€16

Hold

13.31%

Upside

Reiterated

02/11/26

DZ BANK AG Remains a Hold on Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€11.6→€14

Sell

-0.85%

Downside

Reiterated

02/11/26

Berenberg Bank Keeps Their Sell Rating on Evonik (0QDS)

Georgina Fraser CFA

Goldman Sachs

€11.6→€18

Buy

27.48%

Upside

Upgraded

02/10/26

Evonik (0QDS) was upgraded to a Buy Rating at Goldman Sachs

Oliver Schwarz

Warburg Research

€20.4

Hold

44.48%

Upside

Reiterated

02/06/26

Warburg Research Sticks to Their Hold Rating for Evonik (0QDS)

Virginie Boucher-Ferte

Deutsche Bank

€13

Hold

-7.93%

Downside

Reiterated

02/06/26

Deutsche Bank Sticks to Its Hold Rating for Evonik (0QDS)

David Symonds

Exane BNP Paribas

€14

Hold

-0.85%

Downside

Downgraded

01/21/26

Evonik downgraded to Neutral from Outperform at BNP ParibasEvonik downgraded to Neutral from Outperform at BNP Paribas

Thomas Wrigglesworth

Morgan Stanley

€15→€14.7

Hold

4.11%

Upside

Upgraded

01/05/26

Evonik upgraded to Equal Weight from Underweight at Morgan StanleyEvonik upgraded to Equal Weight from Underweight at Morgan Stanley

Sebastian Satz

Citi

€18→€17

Buy

20.40%

Upside

Reiterated

12/11/25

Evonik price target lowered to EUR 17 from EUR 18 at CitiEvonik price target lowered to EUR 17 from EUR 18 at Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anil Shenoy

Barclays

€16→€17

Buy

20.40%

Upside

Upgraded

03/19/26

Barclays upgrades Evonik (0QDS) to a Buy

Martin Roediger

Kepler Capital

€12.7

Sell

-10.06%

Downside

Reiterated

03/10/26

Kepler Capital Sticks to Their Sell Rating for Evonik (0QDS)

Christian Bell

UBS

€13

Hold

-7.93%

Downside

Reiterated

03/04/26

UBS Remains a Hold on Evonik (0QDS)

Chetan Udeshi

J.P. Morgan

―

Hold

―

Reiterated

03/04/26

J.P. Morgan Sticks to Their Hold Rating for Evonik (0QDS)

Chris Counihan

Jefferies

€12.2

Sell

-13.60%

Downside

Reiterated

03/04/26

Jefferies Keeps Their Sell Rating on Evonik (0QDS)

Peter Spengler

DZ BANK AG

€16

Hold

13.31%

Upside

Reiterated

02/11/26

DZ BANK AG Remains a Hold on Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€11.6→€14

Sell

-0.85%

Downside

Reiterated

02/11/26

Berenberg Bank Keeps Their Sell Rating on Evonik (0QDS)

Georgina Fraser CFA

Goldman Sachs

€11.6→€18

Buy

27.48%

Upside

Upgraded

02/10/26

Evonik (0QDS) was upgraded to a Buy Rating at Goldman Sachs

Oliver Schwarz

Warburg Research

€20.4

Hold

44.48%

Upside

Reiterated

02/06/26

Warburg Research Sticks to Their Hold Rating for Evonik (0QDS)

Virginie Boucher-Ferte

Deutsche Bank

€13

Hold

-7.93%

Downside

Reiterated

02/06/26

Deutsche Bank Sticks to Its Hold Rating for Evonik (0QDS)

David Symonds

Exane BNP Paribas

€14

Hold

-0.85%

Downside

Downgraded

01/21/26

Evonik downgraded to Neutral from Outperform at BNP ParibasEvonik downgraded to Neutral from Outperform at BNP Paribas

Thomas Wrigglesworth

Morgan Stanley

€15→€14.7

Hold

4.11%

Upside

Upgraded

01/05/26

Evonik upgraded to Equal Weight from Underweight at Morgan StanleyEvonik upgraded to Equal Weight from Underweight at Morgan Stanley

Sebastian Satz

Citi

€18→€17

Buy

20.40%

Upside

Reiterated

12/11/25

Evonik price target lowered to EUR 17 from EUR 18 at CitiEvonik price target lowered to EUR 17 from EUR 18 at Citi

Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector

xxx

Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evonik

3 Months

xxx

Success Rate

14/24 ratings generated profit

Average Return

+0.44%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +0.44% per trade.

1 Year

Georgina Fraser CFAGoldman Sachs

Success Rate

28/41 ratings generated profit

Average Return

+9.23%

upgraded a buy rating last month

Copying Georgina Fraser CFA's trades and holding each position for 1 Year would result in 68.29% of your transactions generating a profit, with an average return of +9.23% per trade.

2 Years

xxx

Success Rate

27/41 ratings generated profit

Average Return

+10.34%

upgraded a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 65.85% of your transactions generating a profit, with an average return of +10.34% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QDS Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QDS has received 2 Buy Ratings, 20 Hold Ratings, and 9 Sell Ratings. 0QDS average Analyst price target in the past 3 months is 15.00.

Each month's total comprises the sum of three months' worth of ratings.

0QDS Financial Forecast

0QDS Earnings Forecast

Next quarter’s earnings estimate for 0QDS is €0.27 with a range of €0.26 to €0.29. The previous quarter’s EPS was €0.15. 0QDS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 43.91% of the time in the same period. In the last calendar year 0QDS has Performed in-line its overall industry.

0QDS Sales Forecast

Next quarter’s sales forecast for 0QDS is €3.55B with a range of €3.45B to €3.67B. The previous quarter’s sales results were €3.40B. 0QDS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 46.88% of the time in the same period. In the last calendar year 0QDS has Performed in-line its overall industry.

0QDS Stock Forecast FAQ

What is GB:0QDS’s average 12-month price target, according to analysts?

Based on analyst ratings, Evonik’s 12-month average price target is 15.00.

What is GB:0QDS’s upside potential, based on the analysts’ average price target?

Evonik has 6.23% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Evonik a Buy, Sell or Hold?

Evonik has a consensus rating of Hold, which is based on 2 buy ratings, 7 hold ratings and 3 sell ratings.

What is Evonik’s share price target?

The average share price target for Evonik is 15.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €20.40 ,and the lowest forecast is €12.20. The average share price target represents 6.23% Increase from the current price of €14.12.

What do analysts say about Evonik?

Evonik’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Evonik?

To buy shares of GB:0QDS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Evonik (0QDS) Share Forecast & Price Target

0QDS Analyst Ratings

0QDS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Evonik

0QDS Analyst Recommendation Trends

0QDS Financial Forecast

0QDS Earnings Forecast

0QDS Sales Forecast

0QDS Stock Forecast FAQ

Detailed List of Analyst Forecasts